GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cresanto Global Ltd (BOM:531207) » Definitions » Other Income (Expense)

Cresanto Global (BOM:531207) Other Income (Expense) : ₹0.09 Mil (TTM As of Dec. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Cresanto Global Other Income (Expense)?

Cresanto Global's other income expense for the Cresanto Global's pretax income for the three months ended in Dec. 2024 was ₹0.09 Mil. Its other income expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹0.09 Mil.


Cresanto Global Other Income (Expense) Historical Data

The historical data trend for Cresanto Global's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cresanto Global Other Income (Expense) Chart

Cresanto Global Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Other Income (Expense)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.07 - -0.64 -

Cresanto Global Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 0.09

Cresanto Global Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.09 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cresanto Global  (BOM:531207) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Cresanto Global Business Description

Traded in Other Exchanges
N/A
Address
C-273, Sector-63, Noida, UP, IND, 201301
Raymed Labs Ltd is an Indian company engaged in the business of pharmaceutical sector. The company is involved in manufacturing as well as trading medicines and chemicals. Business operations activities include; manufacturers and producers, buyers and sellers, trading, stores and stockists, suppliers and distributors, wholesale and retail dealers in pharmaceuticals, medicals, chemicals, industrial and other preparations and articles, compounds, drugs, veterinary and human medicines, and others.

Cresanto Global Headlines

No Headlines